���沙莫瑞林历史与监管定位 — What the Evidence Shows

By Editorial Desk · published 2026-05-12 · last reviewed 2026-05-29 · Info

If you have been reading about Phase 3 trial and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2026-05-29. Where a claim depends on a specific study, the study is described rather than over-claimed.

特沙莫瑞林历史与监管定位

监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。

在临床研究之外，特沙莫瑞林常被讨论为生长激素分泌促进剂，但这一说法需要限定。它并不等同于生长激素本身，也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力，另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中，尚未形成统一结论。

特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。

Background and Clinical Development

A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.

Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.

Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.

Tesamorelin at a glance

Background And Regulatory Development

Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.

Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.

Related pages on this site

• Measured playbook
• Regional reference
• Scheduled reference
• Scheduled archive
• Portable collection
• Practical briefing
• Durable index
• Technical guide

Identity and Development Background

Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.

Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.

Background and Pharmacology of Tesamorelin

Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.

Notes from published material

Maritime border control measures are controversial in the context of international trade disputes, as was the case following France's detention of British fishermen in October 2021 in the aftermath of Brexit or when the Indonesian navy detained the crew of the Seven Seas Conqueress alleging that the vessel was unlawfully fishing within Indonesian territorial waters while the Singaporean government claimed the vessel was in Singaporean waters near Pedra Branca. Similarly, international law accords each state control over the airspace above its land territory, internal waters, and territorial sea. Consequently, states have the authority to regulate flyover rights and tax foreign aircraft utilising their airspace. Additionally, the International Civil Aviation Organization designates states to administer international airspace, including airspace over waters that do not form part of any state's territorial sea. Aircraft unlawfully entering a country's airspace may be grounded, and their crews may be detained. No country has sovereignty over international waters, including the associated airspace. All states have the freedom to fish, navigate, overfly, lay cables and pipelines, and conduct research. Oceans, seas, and waters outside national jurisdiction are also referred to as the high seas or, in Latin, mare liberum (meaning free sea).

nuclear equivalence The principle that the nuclei of essentially all differentiated cells of a mature multicellular organism are genetically identical to each other and to the nucleus of the zygote from which they descended; i.e. they all contain the same genetic information on the same chromosomes, having been replicated from the original zygotic set with extremely high fidelity. Even though all adult somatic cells have the same set of genes, cells can nonetheless differentiate into distinct cell types by expressing different subsets of these genes. Though this principle generally holds true, the reality is slightly more complex, as mutations such as insertions, deletions, duplications, and translocations as well as chimerism, mosaicism, and various types of genetic recombination can all cause different somatic lineages within the same organism to be genetically non-identical.

Football is the most popular sport in Romania with over 219,000 registered players as of 2018. The market for professional football in Romania was roughly €740 million in 2018 according to UEFA. The governing body is the Romanian Football Federation, which belongs to UEFA. The Romania national football team played its first match in 1922 and is one of only four national teams to have taken part in the first three FIFA World Cups, the other three being Brazil, France, and Belgium. Overall, it has played in seven World Cups and had its most successful period during the 1990s, when it finished 6th at the 1994 FIFA World Cup, eventually being ranked 3rd by FIFA in 1997. The most successful club is Steaua București, who were the first Eastern European team to win the UEFA Champions League in 1986, and were runners-up in 1989. Dinamo București reached the UEFA Champions League semi-final in 1984 and the UEFA Cup Winners' Cup semi-final in 1990. Other important Romanian football clubs are Rapid București, UTA Arad, Universitatea Craiova, Petrolul Ploiești, CFR Cluj, Astra Giurgiu, and Viitorul Constanța (the latter having recently merged with FCV Farul Constanța). Tennis is the second most popular sport. Romania reached the Davis Cup finals three times in 1969, 1971 and 1972. The second most popular team sport is handball. The men's team won the handball world championship in 1961, 1964, 1970, 1974 making them the third most successful nation ever in the tournament.

As these animals have faster metabolisms and much shorter lifespans than humans results from experiments are received sooner, speeding research. The 1997 discovery that mHTT fragments misfold led to the discovery of the nuclear inclusions they cause. These advances have led to increasingly extensive research into the proteins involved with the disease, potential drug treatments, care methods, and the gene itself. The networks of care and support that had developed in Venezuela and Colombia during the research projects there in the 1970s through 2000s were eventually eroded by various forces, such as the ongoing crisis in Venezuela and the death of a lead researcher in Colombia (Jorge Daza Barriga). Doctors are working toward rekindling these networks because the people who have contributed to the science of HD by participating in these studies deserve adequate follow-up care; societies elsewhere in the world who benefit from the scientific advances thus achieved owe at least that much to those who participated in the research. The condition was formerly called Huntington's chorea. The term was superseded by Huntington's disease because not all patients develop chorea; furthermore, cognitive and behavioral problems constitute a significant portion of HD symptomatology.

Alonso de Ojeda (who had sailed with Columbus) reached the Guajira Peninsula in 1499. Spanish explorers, led by Rodrigo de Bastidas, made the first exploration of the Caribbean coast in 1500. Christopher Columbus navigated near the Caribbean in 1502. In 1508, Vasco Núñez de Balboa accompanied an expedition to the territory through the region of Gulf of Urabá and they founded the town of Santa María la Antigua del Darién in 1510, the first stable settlement on the continent. Santa Marta was founded in 1525, and Cartagena in 1533. Spanish conquistador Gonzalo Jiménez de Quesada led an expedition to the interior in April 1536, and christened the districts through which he passed "New Kingdom of Granada". In August 1538, he provisionally founded its capital near the Muisca cacicazgo of Muyquytá, and named it "Santa Fe". The name soon acquired a suffix and was called Santa Fe de Bogotá. Two other notable journeys by early conquistadors to the interior took place in the same period. Sebastián de Belalcázar, conqueror of Quito, traveled north and founded Cali, in 1536, and Popayán, in 1537; from 1536 to 1539, German conquistador Nikolaus Federmann crossed the Llanos Orientales and went over the Cordillera Oriental in a search for El Dorado, the "city of gold". The legend and the gold would play a pivotal role in luring the Spanish and other Europeans to New Granada during the 16th and 17th centuries. The conquistadors made frequent alliances with the enemies of different indigenous communities.

Sources: en.wikipedia.org

Further detail

Additionally, one trial aimed to assess its role in preventing actinic keratosis in organ transplant recipients. Further trials were pursued for the first two conditions, while results for the latter three were not published. Following the initial trials, research efforts centered on erythropoietic protoporphyria, and due to the epidemiology of the condition. Clinuvel secured orphan drug for afamelanotide in both the US and the EU by 2010. The first approval of afamelanotide came in May 2010 from the Italian Medicines Agency (AIFA, or Agenzia Italiana del Farmaco), followed by the European Medicines Agency (EMA) in January 2015. Both approvals were for the treatment of erythropoietic protoporphyria. The US Food and Drug Administration (FDA) granted approval in October 2019 for the use of afamelanotide as a medication to alleviate pain caused by sun exposure in individuals with erythropoietic protoporphyria. This decision was largely based on three trials involving 244 adults aged 18–74 across 22 sites in the US and Europe, which had a focus on pain-free hours in sunlight, outdoor hours under varying light conditions, and side effects. The FDA designated it as a first-in-class medication, meaning it had a novel mechanism different from previously approved medications. Between 2022 and 2023, trials were outlined to study the effects of afamelanotide on xeroderma pigmentosum and variegate porphyria, along with two additional trials exploring its impact on vitiligo. According to the register, as of April 2025, most of these trials are currently in the recruitment phase.

knockin (KI) A genetic engineering method in which one or more novel genes are inserted into an organism's genome, particularly when targeted to a specific locus, or in which one or more existing genes are replaced by or substituted with novel genes. This is in contrast to a knockout, in which a gene is deleted or completely inactivated.

=== Final meeting with Tho === At the time of the Christmas bombings, a columnist for the New York Times, Scotty Reston, stated that, based on unnamed sources, Kissinger was opposed to the Christmas bombings and was planning to write a book that "would probably be highly embarrassing to Mr. Nixon" if he were fired. Nixon accused Kissinger of talking to Reston, which he denied, until he was caught out when the White House phone log showed that he called Reston several times just before his column ran. On 26 December 1972, in a press statement, Hanoi indicated a willingness to resume the Paris peace talks, provided that the bombing stop. On 8 January 1973, Kissinger and Tho met again in Paris and reached an agreement the next day, which, in its main points, was essentially the same as the one Nixon had rejected in October with only cosmetic concessions to the Americans. At his meeting with Tho on 8 January 1973 in a house in the French town of Gif-sur-Yvette, Kissinger arrived to find nobody at the door to greet him. When Kissinger entered the conference room, nobody spoke to him. Sensing the hostile mood, Kissinger, speaking in French, said: "It was not my fault about the bombing". Before Kissinger could say anymore, Tho exploded in rage, saying in French: "Under the pretext of interrupted negotiations, you resumed the bombing of North Vietnam, just at the moment when I reached home. You have 'greeted' my arrival in a very courteous manner! Your action, I can say, is flagrant and gross! You and no one else strained the honor of the United States".

== Further reading == Zhu, Wenyou; Guo, Chunxia; Luo, Fan (January 2015). "Optimization of Calvatia gigantea myceliaproduction from distillery wastewater". Journal of the Institute of Brewing. 121 (1): 78–86. doi:10.1002/jib.200. Kivrak, Ibrahim; Kivrak, Seyda; Harmandar, Mansur (1 September 2014). "Free amino acid profiling in the giant puffball mushroom (Calvatia gigantea) using UPLC-MS/MS". Food Chemistry. 158: 88–92. doi:10.1016/j.foodchem.2014.02.108. PMID 24731318. Coetzee, Johannes C.; Van Wyk, Abraham E. (January 2013). "Nomenclatural and taxonomic notes on Calvatia (Lycoperdaceae) and associated genera". Mycotaxon. 121 (1): 29–36. doi:10.5248/121.29. hdl:2263/21213.

Sources: en.wikipedia.org

Frequently asked questions